Corrie P, Marshall A, Lorigan P, et al. Adjuvant bevacizumab as treatment for melanoma patients at high risk of recurrence: final results for the AVAST-M Trial. J Clin Oncol 35, 2017 (suppl; abstr 9501).
Studies tonen belofte neoadjuvante behandeling melanoom
apr 2019 | Dermato-oncologie, Immuuntherapie